全文获取类型
收费全文 | 4371篇 |
免费 | 218篇 |
国内免费 | 14篇 |
专业分类
耳鼻咽喉 | 16篇 |
儿科学 | 323篇 |
妇产科学 | 68篇 |
基础医学 | 516篇 |
口腔科学 | 176篇 |
临床医学 | 290篇 |
内科学 | 769篇 |
皮肤病学 | 74篇 |
神经病学 | 238篇 |
特种医学 | 229篇 |
外科学 | 543篇 |
综合类 | 168篇 |
一般理论 | 2篇 |
预防医学 | 229篇 |
眼科学 | 119篇 |
药学 | 583篇 |
1篇 | |
中国医学 | 18篇 |
肿瘤学 | 241篇 |
出版年
2022年 | 62篇 |
2021年 | 99篇 |
2020年 | 56篇 |
2019年 | 67篇 |
2018年 | 93篇 |
2017年 | 70篇 |
2016年 | 77篇 |
2015年 | 98篇 |
2014年 | 165篇 |
2013年 | 180篇 |
2012年 | 260篇 |
2011年 | 272篇 |
2010年 | 162篇 |
2009年 | 161篇 |
2008年 | 218篇 |
2007年 | 231篇 |
2006年 | 198篇 |
2005年 | 180篇 |
2004年 | 155篇 |
2003年 | 148篇 |
2002年 | 127篇 |
2001年 | 119篇 |
2000年 | 103篇 |
1999年 | 89篇 |
1998年 | 61篇 |
1997年 | 82篇 |
1996年 | 66篇 |
1995年 | 48篇 |
1994年 | 45篇 |
1993年 | 51篇 |
1992年 | 85篇 |
1991年 | 64篇 |
1990年 | 70篇 |
1989年 | 65篇 |
1988年 | 64篇 |
1987年 | 49篇 |
1986年 | 59篇 |
1985年 | 46篇 |
1984年 | 36篇 |
1983年 | 33篇 |
1982年 | 25篇 |
1981年 | 27篇 |
1980年 | 16篇 |
1979年 | 21篇 |
1977年 | 22篇 |
1976年 | 26篇 |
1975年 | 17篇 |
1974年 | 17篇 |
1973年 | 20篇 |
1972年 | 15篇 |
排序方式: 共有4603条查询结果,搜索用时 0 毫秒
61.
62.
Repeated infusions of identical doses of norepinephrine show potentiation of metabolic responses in human subjects 总被引:1,自引:0,他引:1
Thermogenic responses to similar doses of norepinephrine appear to be different when repeatedly administered. This hypothesis was tested by three consecutive 30-minute infusions of a fixed dose of norepinephrine separated by a rest period of one hour between infusions. There was a significant increase or potentiation of the metabolic response as measured by oxygen consumption to the third dose of norepinephrine, while the cardiovascular responses showed no change. It is therefore important to make allowances for this phenomenon when assessing intergroup differences in regulatory thermogenesis using dose-response protocols for norepinephrine administration. 相似文献
63.
Cytogenetic and histologic correlations in malignant lymphoma 总被引:9,自引:0,他引:9
Koduru PR; Filippa DA; Richardson ME; Jhanwar SC; Chaganti SR; Koziner B; Clarkson BD; Lieberman PH; Chaganti RS 《Blood》1987,69(1):97-102
Although a number of studies have indicated correlations between histologic subtypes of tumors and certain nonrandom chromosome changes, cytogenetic studies of lymphoma are in an early stage compared to those of leukemia. No comprehensive analysis of available data has so far been attempted in the literature either. Here we present an analysis of chromosome changes and their correlation with subtypes of lymphoma studied by conventional histology and cell surface markers, as observed in two sets of data: a group of 65 karyotypically abnormal tumors sequentially ascertained and studied by us during the period January 1, 1984 to April 30, 1985, and a larger data set derived by combining our data with those from two published series from the University of Minnesota that are comparable to our data. These combined data, which comprise the largest data set on the cytogenetics of lymphomas assembled so far, enabled a comprehensive analysis of correlation between chromosome change and tumor histology and the patterns of chromosome instability in these tumors. We found several significant associations, some previously described and others now recognized, between nonrandom chromosome gains, breaks, translocations, and deletions and histologic subtypes of tumors that characterize lymphomas. The data indicate that finding of chromosome breaks at certain sites (eg, 8q24, 14q32, 18q21) is of diagnostic value in dealing with cases of unusual lymphoma. Furthermore, nonrandom chromosome breakage exhibited three distinct patterns that reflected three levels of etiologically relevant genetic change. 相似文献
64.
65.
Promadej N Costello C Wernett MM Kulkarni PS Robison VA Nelson KE Hodge TW Suriyanon V Duerr A McNicholl JM 《The Journal of infectious diseases》2003,187(7):1053-1063
Eighteen highly exposed but persistently seronegative (HEPS) women (HW) and their human immunodeficiency virus (HIV) type 1-seropositive male partners were studied for HIV-specific T cells and other host factors. Circulating HIV-specific T cells were measured by interferon-gamma enzyme-linked immunospot assays, using recombinant vaccinia virus vectors expressing HIV proteins. Nine (50%) of the HW and all HIV-seropositive persons had HIV-specific T cell responses. Only 2 (22%) of the HEPS responders recognized Env, compared with 94% of HIV-seropositive persons. A high percentage (75%) of the HW with HIV-specific T cell responses reported recent HIV exposure. Remarkably, however, long-lived HIV-specific T cells were detected in 2 HW who had an extended period (>3.9 years) of no HIV exposure. These findings have important implications for HIV vaccine design. 相似文献
66.
Mehta J Powles R Sirohi B Treleaven J Swansbury GJ Kulkarni S Saso R Singhal S 《Bone marrow transplantation》2003,32(2):157-164
A total of 81 adults with acute myeloid leukemia (AML) (47% favorable karyotypes) were autografted in first remission after melphalan-total body irradiation, having received 0 (n=7), 1 (n=19), 2 (n=51), or 3 (n=4) consolidation chemotherapy cycles before harvest. The cumulative 5-year incidences of relapse and transplant-related mortality were 37 and 17%, respectively. The actuarial 5-year probability of disease-free survival (DFS) was 46%. In Cox analysis, favorable karyotypes, increasing numbers of consolidation cycles (0 vs > or =1 or 1 vs >1), and higher nucleated cell doses were associated with lower relapse rates and higher DFS. Patients with favorable karyotypes benefited from every additional cycle of consolidation therapy (0 vs > or =1 as well as 1 vs >1). Among patients with other karyotypes, while the benefit of one cycle of consolidation was clear (0 vs > or =1), there was no obvious beneficial impact of further consolidation therapy (1 vs >1). Administration of consolidation chemotherapy prior to harvest is essential in AML. While it is possible to enhance the benefit of consolidation with favorable karyotypes by delivering two cycles, its usefulness is limited in others. In them, it may be worthwhile exploring alternatives not normally used in AML (eg high-dose cyclophosphamide) that could have antileukemic effects while permitting mobilization of stem cells. 相似文献
67.
R. K. Menda M.D. H. L. Chulani M.D. S. J. Yawalkar M.D. B. S. Kulkarni M.D. 《Diseases of the colon and rectum》1971,14(6):454-459
Summary Thirty cases of venereal and related anal affections seen at G. T. Hospital have been reviewed. Occupational factors in the
etiology of the disease, as well as other factors, have been stressed. Multiple fissures of the nonsyphilitic type were the
lesions most often encountered. The types of diseases seen and their treatment have been described. 相似文献
68.
Powles R Sirohi B Kulkarni S Treleaven J Rudin C Sankpal S Goyal S Horton C Millar B Saso R Singhal S Mehta J 《Bone marrow transplantation》2002,30(8):479-484
We have shown that primary therapy with non-myeloablative (140 mg/m(2)) high-dose melphalan (HDM) without hematopoietic support results in high response rates in untreated myeloma and very long-term survival of some patients. This study was designed to see if sufficient CD34 (+) cells can be harvested at presentation in newly diagnosed patients to administer myeloablative HDM (200 mg/m(2); HDM200) with autograft as primary therapy. This may improve outcome by rapid achievement of complete remission (CR) and possible avoidance of late myelodysplasia as a consequence of non-transplant induction chemotherapy. Thirty untreated patients received 1 g/m(2) methylprednisolone daily (days 1-6) and 12-16 micro g/kg G-CSF daily (days 3-6), and underwent leukapheresis on days 6 and 7. The median CD34(+) cell yield was 1.31 x10(6)/kg (range, 0.23-5.63), and was > or =1 x10(6)/kg in 73%. Cell yields were significantly lower than in 82 historical controls apheresed after completion of induction chemotherapy (median 2.16 x 10(6)/kg), and improved in patients who were apheresed again after induction chemotherapy. Three patients received primary therapy with HDM200 and autograft using these cells and attained CR. We conclude that it is possible to harvest stem cells in three-quarters of untreated myeloma patients. Increasing the number of apheresis procedures is needed to improve the number of CD34(+) cells collected. 相似文献
69.
Testicular metastasis presenting as a testicular mass is an extremely rare condition. There are only nine previously reported cases where testicular mass was the first clinical manifestation of underlying malignancy. Here we report a case of metastatic mucin secreting adenocarcinoma in testis presenting as a testicular mass with unknown primary. We have given a brief review of literature about the spread of tumor to testes. 相似文献
70.
Kulkarni S Powles RL Treleaven JG Singhal S Saso R Horton C Killick S Tait D Ramiah V Mehta J 《Bone marrow transplantation》1999,23(7):675-680
We describe a single centre experience of 33 patients allografted for multiple myeloma, of which 28 received matched sibling marrow, one haploidentical family donor marrow and four matched but unrelated donor marrow. Median follow-up after transplant is 27 months, and 13 patients are currently alive. One out of four patients with an unrelated donor survives and 12 out of 28 (42.8%) with matched sibling donors. Four patients were unevaluable because of early death (相似文献